Among Patients With Myeloma Undergoing Chemo, High Exercise Compliance Linked With Reduced Fatigue
the ONA take:
Among patients with multiple myeloma, high compliance with exercise was associated with improvements in fatigue, according to a study published in the October 2015 issue of the journal Supportive Care in Cancer.
Because exercise is considered beneficial and safe in patients with multiple myeloma, which is commonly associated with osteolytic bone disease and anemia, resulting in skeletal fragility, persistent fatigue, pain, and reduced quality of life, researchers at the Jewish General Hospital in Montreal, Canada, sought to evaluate the extent of exercise compliance in this patient population.
For the retrospective study, researchers analyzed data from 41 patients with multiple myeloma who participated in a hospital-based rehabilitation program while undergoing chemotherapy. Results showed that exercise compliance was 71% at follow-up and was associated with a decrease in fatigue severity scores.
Researchers found that participants with a history of pathological fracture, spinal cord compression, or radiation were at an increased risk for noncompliance and may therefore require additional supervision to improve exercise compliance.
Among patients with multiple myeloma, high compliance with exercise was associated with improvements in fatigue.
- Osteoporosis Medication Improves Bone Health in ADT-Treated Prostate Cancer
- Inotuzumab Ozogamicin Granted FDA Approval for Acute Lymphoblastic Leukemia
- Cabazitaxel in Prostate Cancer: Reduced Dose Noninferior to Standard Dose
- Risk of Some Cancers Higher in Women With a History of Periodontal Disease
- Breast Conservation Improves Survival vs Mastectomy in Breast Cancer
- To Better Serve Patients With Cancer, Navigators Need Better Systems
- Physical Activity Improves Cognitive Function for Breast Cancer Survivors
- Risk of Lung Cancer Increases With Diets Higher in Saturated Fats
- Mechanisms Identified for Curcumin Resensitization of Cancer Cells
- Value of Type and Crossmatch Prior to Daratumumab Administration
- Affect of Daratumumab on Laboratory Blood Test Results
- Geriatric Consults Rare in Kidney Cancer Care
- Worse Survival Seen for Alternative Versus Usual Cancer Therapy
- Anorexia-Cachexia in Non-Small Cell Lung Cancer Improved With Anamorelin
- Early Recognition of Checkpoint Inhibitor-Related Pneumonitis Improves Outcomes
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|